Prostate Cancer | Proceedings from a live event held adjunct to the American Urological Association’s Annual Meeting

Featuring perspectives from Drs Leonard Gomella, Maha Hussain, A Oliver Sartor and Neal Shore, including the following topics: Nonmetastatic (M0) Castration-Resistant Prostate Cancer (CRPC) Introduction: Personalized Continuing Medical Education (0:00) Case: A man in his early 70s with M0 CRPC — Gordon A Brown, DO (9:48) Case: A man in his late 70s with M0 CRPC — Sulfi Ibrahim, MD (17:13) Case: A man in his mid-70s with M0 CRPC — Jason Hafron, MD (22:11) Metastatic Hormone-Sensitive Prostate Cancer Case: A man in his late 60s with metastatic hormone-sensitive prostate cancer — Dr Brown (38:40) PARP Inhibitors in the Management of Metastatic CRPC (mCRPC) Case: A man in his mid-50s with mCRPC and a BRCA2 mutation — Dr Brown (48:53) Case: A man in his mid-70s with mCRPC and a somatic BRCA2 homozygous deletion — Dr Hafron (1:13:08) Case: A man in his mid-70s with mCRPC and a BRCA2 mutation — Dr Ibrahim (1:18:36) CME information and select publications